These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 27749548

  • 1. Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).
    Qvarnström M, Kahan T, Kieler H, Brandt L, Hasselström J, Boström KB, Manhem K, Hjerpe P, Wettermark B.
    Medicine (Baltimore); 2016 Oct; 95(40):e4908. PubMed ID: 27749548
    [Abstract] [Full Text] [Related]

  • 2. Persistence to antihypertensive drug treatment in Swedish primary healthcare.
    Qvarnström M, Kahan T, Kieler H, Brandt L, Hasselström J, Bengtsson Boström K, Manhem K, Hjerpe P, Wettermark B.
    Eur J Clin Pharmacol; 2013 Nov; 69(11):1955-64. PubMed ID: 23857249
    [Abstract] [Full Text] [Related]

  • 3. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M, Krueger K, Schuessel K, Friedland K, Laufs U, Mueller WE, Ude M.
    Int J Cardiol; 2016 Oct 01; 220():668-76. PubMed ID: 27393848
    [Abstract] [Full Text] [Related]

  • 4. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
    Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP.
    J Hypertens; 2005 Nov 01; 23(11):2093-100. PubMed ID: 16208153
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.
    Baggarly SA, Kemp RJ, Wang X, Magoun AD.
    Res Social Adm Pharm; 2014 Nov 01; 10(6):e99-e112. PubMed ID: 24731547
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun 01; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 8. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep 01; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study.
    Hasford J, Schröder-Bernhardi D, Rottenkolber M, Kostev K, Dietlein G.
    Eur J Clin Pharmacol; 2007 Nov 01; 63(11):1055-61. PubMed ID: 17701032
    [Abstract] [Full Text] [Related]

  • 11. Drug adherence in treatment resistant and in controlled hypertension-Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Holmqvist L, Boström KB, Kahan T, Schiöler L, Qvarnström M, Wettermark B, Hjerpe P, Hasselström J, Manhem K.
    Pharmacoepidemiol Drug Saf; 2018 Mar 01; 27(3):315-321. PubMed ID: 29349834
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

  • 14. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM, Lee JY, Choi YJ, Kim B, Choi KH, Kong J, Oh JM, Shin WG, Lee HY.
    J Korean Med Sci; 2015 Dec 15; 30(12):1800-6. PubMed ID: 26713055
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive persistence and drug class.
    Marentette MA, Gerth WC, Billings DK, Zarnke KB.
    Can J Cardiol; 2002 Jun 15; 18(6):649-56. PubMed ID: 12107422
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Jan 03; 157(1):30-4. PubMed ID: 26708684
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term persistence and adherence to blood pressure lowering agents among older Australians.
    Si S, Ofori-Asenso R, Briffa T, Sanfilippo FM, Ilomaki J, Qin X, Tacey M, Reid CM, Liew D.
    Pharmacoepidemiol Drug Saf; 2019 Jun 03; 28(6):788-795. PubMed ID: 30784140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.